OrbisResearch.com has published “Global Hemophilia Market Report: Insights, Trends and Forecast (2019-2023)” report to its research database. The key Players: Pfizer Inc., Bayer Group, Sanofi S.A., Takeda Pharmaceutical Company, Novo Nordisk and CSL Limited
Dallas, Texas - July 8, 2019 /MarketersMedia/ —
The global hemophilia market is estimated to reach US$12.98 billion in 2023, holding a CAGR of 6.21% in the duration spanning 2018-2023. The factors such as rise in diagnoses rate of hemophilia, rise in global healthcare expenditure and shifting focus to extended half-life (EHL) therapies are expected to drive the growth of the global hemophilia market. However, growth of the industry will be challenged by high price of treatment and reluctance to switch to new therapies. A few notable trends include shifting focus to Extended Half Life (EHL) therapies, development of novel hemophilia treatments and popularity of gene therapy.
Browse the full report@https://www.orbisresearch.com/reports/index/global-hemophilia-market-report-insights-trends-and-forecast-2019-2023
The global hemophilia market comprises of two major segments: hemophilia A and hemophilia B. hemophilia A is four time prevalent than hemophilia B. The growing incidences of hemophilia A at vast rate has driven the increased demand for anti-hemophilia A or clotting factor VIII drugs. The pharmaceutical industry is flooded with drugs to be used in the treatment of type A, and thereby providing scope for the expansion of the global hemophilia market.
The fastest growing regional market in the hemophilia space is the U.S. due to High prevalence of hemophilia, coupled with rising inclination toward prophylaxis treatment. Rise in the population of hemophilia patients, is augmenting the need for more significant treatment methods. A lot of anti-hemophilia products are available in the market and several drugs are still in their late stage clinical process by large pharmaceutical firms. Furthermore, The U.S. and Europe are the highly established premium markets that contribute to considerable shares in the global hemophilia market.
Request a sample@https://www.orbisresearch.com/contacts/request-sample/3416064
Scope of the report:
• The report provides a comprehensive analysis of the global hemophilia market, segmented into hemophilia A and hemophilia B.
• The major regional markets (the U.S. and Europe) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Pfizer Inc., Bayer Group, Sanofi S.A., Takeda Pharmaceutical Company, Novo Nordisk and CSL Limited) are also presented in detail.
Key Target Audience:
• Hemophilia Drugs Manufacturers
• Raw Material Suppliers
• End Users (Hospital, Medical centers, Clinical Institutes)
• Healthcare Consulting Firms
• Investment Banks
• Government Bodies & Regulating Authorities
Some points from Table of Contents:
1. Market Overview
1.1 Hemophilia
1.2 Types of Hemophilia
1.3 Signs & Symptoms
1.4 Diagnosis of Hemophilia
1.5 Treatment of Hemophilia
2. Global Market Analysis
2.1 Global Hemophilia Market by Value
2.2 Global Hemophilia Market Forecast by Value
2.3 Global Hemophilia Market by Treatment Regimen
2.4 Global Hemophilia Market by Type
2.4.1 Global Hemophilia A Market Forecast by Value
2.4.2 Global Hemophilia A Market by Severity
2.4.3 Global Hemophilia A Market by Treatment Type
2.4.4 Global Hemophilia A Market by Treatment Regimen
2.4.5 Global Hemophilia B Market Forecast by Value
2.4.6 Global Hemophilia B Market by Severity
2.4.7 Global Hemophilia B Market by Treatment Type
2.4.8 Global Hemophilia B Market by Treatment Regimen
Continued…
Buy the report@https://www.orbisresearch.com/contact/purchase-single-user/3416064
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: sales@orbisresearch.com
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A
Phone: +1 (214) 884-6817
Website: https://www.orbisresearch.com/reports/index/global-hemophilia-market-report-insights-trends-and-forecast-2019-2023
Source: MarketersMedia
Release ID: 88893387
